Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 19, 2019 07:00 ET | Source: NeoGenomics, Inc.

NeoGenomics Reports Record Revenue of $76 Million with 17% Organic Revenue Growth in the Fourth Quarter

FT. MYERS, Fla., Feb. 19, 2019 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, today reported its results for the fourth quarter...
January 28, 2019 07:00 ET | Source: NeoGenomics, Inc.

NeoGenomics Schedules its Fourth Quarter and Fiscal Year 2018 Earnings Release for February 19, 2019

FT. MYERS, Fla., Jan. 28, 2019 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, announced today that it plans to release its fourth...
December 13, 2018 07:00 ET | Source: NeoGenomics, Inc.

NeoGenomics Appoints Dr. Lawrence M. Weiss as Chief Scientific Officer

FT. MYERS, Fla., Dec. 13, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, today announced the appointment of Lawrence M....
December 12, 2018 07:35 ET | Source: NeoGenomics, Inc.

NeoGenomics Announces Pricing on Secondary Offering of Common Stock by Selling Stockholder

FT. MYERS, Fla., Dec. 12, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, today announced the pricing of an underwritten...
December 11, 2018 16:10 ET | Source: NeoGenomics, Inc.

NeoGenomics Announces Secondary Offering of Common Stock by Selling Stockholder

FORT MYERS, Fla., Dec. 11, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, today announced that GE Medical Systems...
December 10, 2018 09:10 ET | Source: NeoGenomics, Inc.

NeoGenomics Completes Acquisition of Genoptix, Inc.

FT. MYERS, Fla., Dec. 10, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, announced today that it has completed the...
November 30, 2018 17:01 ET | Source: NeoGenomics, Inc.

QIAGEN and NeoGenomics collaborate to offer cancer patients Day-One access to innovative companion diagnostics for newly approved drugs

Partners discuss efforts to accelerate precision medicine solutions at ASH 2018 HILDEN, Germany and GERMANTOWN, Md. and FORT MYERS, Fla., Nov. 30, 2018 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN;...
October 30, 2018 07:00 ET | Source: NeoGenomics, Inc.

NeoGenomics Reports 17% Revenue Growth to Record $69 Million

FT. MYERS, Fla., Oct. 30, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, today reported its results for the third quarter of...
October 23, 2018 07:00 ET | Source: NeoGenomics, Inc.

NeoGenomics Signs Definitive Agreement to Acquire Genoptix

FT. MYERS, Fla., Oct. 23, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, announced today that it has entered into a...
October 01, 2018 07:00 ET | Source: NeoGenomics, Inc.

NeoGenomics Schedules its Third Quarter Earnings Release for October 30, 2018

FT. MYERS, Fla., Oct. 01, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, announced today that it plans to release its third...